Board Meeting5 Aug 2026, 05:00 pm
Brawn Biotech Board Meeting on Aug 13 to Approve Un-Audited Results
AI Summary
Brawn Biotech Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda item for this meeting is to consider and approve the company's Un-Audited Financial Results for the quarter ended June 30, 2026. The trading window for dealing in the company's securities will remain closed until August 15, 2026, and will reopen on August 16, 2026, in accordance with SEBI regulations and the company's insider trading code.
Key Highlights
- Board meeting scheduled for August 13, 2026.
- To consider and approve Un-Audited Financial Results.
- Results are for the quarter ended June 30, 2026.
- Trading window closure extended until August 15, 2026.
- Trading window reopens on August 16, 2026.
Price Impact
More from BRAWN